Name | Number of supported studies | Average coverage | |
---|---|---|---|
lung | 18 studies | 33% ± 12% | |
peripheral blood | 17 studies | 35% ± 13% | |
brain | 17 studies | 34% ± 19% | |
intestine | 11 studies | 28% ± 12% | |
eye | 11 studies | 27% ± 10% | |
kidney | 8 studies | 28% ± 5% | |
liver | 6 studies | 35% ± 20% | |
lymph node | 5 studies | 31% ± 6% | |
pancreas | 4 studies | 56% ± 18% | |
bone marrow | 4 studies | 31% ± 9% | |
heart | 4 studies | 21% ± 2% | |
uterus | 4 studies | 40% ± 16% | |
breast | 4 studies | 29% ± 4% | |
prostate | 4 studies | 40% ± 17% | |
placenta | 3 studies | 58% ± 7% | |
skin | 3 studies | 23% ± 7% | |
adipose | 3 studies | 25% ± 3% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 9112.84 | 1445 / 1445 | 100% | 64.52 | 183 / 183 |
lung | 100% | 9063.33 | 578 / 578 | 100% | 52.42 | 1155 / 1155 |
ovary | 100% | 11388.41 | 180 / 180 | 100% | 41.31 | 430 / 430 |
prostate | 100% | 9257.18 | 245 / 245 | 100% | 45.74 | 502 / 502 |
breast | 100% | 9065.46 | 459 / 459 | 100% | 57.79 | 1117 / 1118 |
brain | 100% | 6530.61 | 2638 / 2642 | 100% | 37.69 | 705 / 705 |
intestine | 100% | 10007.26 | 966 / 966 | 100% | 47.80 | 526 / 527 |
bladder | 100% | 9738.00 | 21 / 21 | 100% | 44.34 | 503 / 504 |
uterus | 100% | 10973.21 | 170 / 170 | 100% | 46.42 | 457 / 459 |
thymus | 100% | 9666.05 | 653 / 653 | 100% | 37.70 | 602 / 605 |
pancreas | 100% | 7000.02 | 328 / 328 | 99% | 39.49 | 177 / 178 |
stomach | 100% | 7580.15 | 359 / 359 | 99% | 51.57 | 284 / 286 |
kidney | 100% | 7530.20 | 89 / 89 | 99% | 35.54 | 892 / 901 |
adrenal gland | 100% | 10382.16 | 258 / 258 | 98% | 35.56 | 226 / 230 |
liver | 100% | 5415.61 | 226 / 226 | 98% | 25.58 | 398 / 406 |
skin | 100% | 8957.14 | 1808 / 1809 | 97% | 42.74 | 456 / 472 |
adipose | 100% | 9235.00 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 8075.70 | 1335 / 1335 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 40.92 | 29 / 29 |
spleen | 100% | 10382.28 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 44.09 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 16.17 | 1 / 1 |
muscle | 100% | 5165.05 | 802 / 803 | 0% | 0 | 0 / 0 |
heart | 99% | 6774.34 | 853 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 96% | 7183.76 | 892 / 929 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 94% | 25.60 | 75 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0031124 | Biological process | mRNA 3'-end processing |
GO_0180010 | Biological process | co-transcriptional mRNA 3'-end processing, cleavage and polyadenylation pathway |
GO_0180011 | Biological process | cytosolic mRNA polyadenylation |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005737 | Cellular component | cytoplasm |
GO_0005634 | Cellular component | nucleus |
GO_0030145 | Molecular function | manganese ion binding |
GO_1990817 | Molecular function | poly(A) RNA polymerase activity |
GO_0005524 | Molecular function | ATP binding |
GO_0005515 | Molecular function | protein binding |
GO_0000287 | Molecular function | magnesium ion binding |
GO_0003723 | Molecular function | RNA binding |
Gene name | PAPOLA |
Protein name | polynucleotide adenylyltransferase (EC 2.7.7.19) Poly(A) polymerase alpha Poly(A) polymerase (EC 2.7.7.19) Poly(A) polymerase alpha (PAP-alpha) (EC 2.7.7.19) (Polynucleotide adenylyltransferase alpha) Alternative protein PAPOLA |
Synonyms | hCG_24516 PAP |
Description | FUNCTION: Polymerase that creates the 3'-poly(A) tail of mRNA's. Also required for the endoribonucleolytic cleavage reaction at some polyadenylation sites. May acquire specificity through interaction with a cleavage and polyadenylation specificity factor (CPSF) at its C-terminus. . FUNCTION: Polymerase that creates the 3'-poly(A) tail of mRNA's. . |
Accessions | A0A0C4DGK1 ENST00000557320.5 [P51003-2] G3V457 ENST00000556619.5 ENST00000553689.5 G3V3I9 H0YJL4 ENST00000556459.1 P51003 ENST00000216277.13 [P51003-1] ENST00000392990.6 ENST00000557471.5 H0YJ00 ENST00000553461.1 L8ECL5 G3XAH6 |